サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1448022

卵殻膜誘導体市場：2023年～2030年

Eggshell Membrane Derivatives Market - 2023-2030

出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
卵殻膜誘導体市場：2023年～2030年
出版日: 2024年03月08日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

卵殻膜誘導体の世界市場は、2022年に7億8,910万米ドルに達し、2023年から2030年にかけてCAGR 6.8%で成長し、2030年には13億3,567万米ドルに達すると予測されています。

卵殻膜誘導体は、タンパク質、コラーゲン、グリコサミノグリカン、エラスチン、その他の必須栄養素を豊富に含んでいるため、様々な医薬品、栄養補助食品、化粧品業界の間で需要が高まっており、これが世界の卵殻膜誘導体市場の成長に寄与しています。

さらに、卵殻膜誘導体製品の需要が高まっているため、様々な業界のメーカーが革新的に卵殻膜を開発し、ポートフォリオに組み込んでいます。例えば、2021年10月、アンシェント・ニュートリション社はコラーゲンペプチドの新ラインを発売しました。このペプチドは発酵卵殻膜で、健康な髪、皮膚、爪、関節、腸をサポートします。このペプチドはまた、カラスの足跡を改善し、関節の不快感を軽減し、関節の回復を早め、コラーゲンの分解を抑えます。

卵殻膜抽出物で作られたカプセルは、卵殻膜誘導体の世界市場で最大のシェアを占めており、欧州地域が世界シェアで優位を占めています。

ダイナミクス

関節痛治療における卵殻膜誘導体需要の増加

製薬業界では、合成成分の代替品として卵殻膜誘導体を使用するケースが増えています。これらの誘導体には、コラーゲン、グルコサミン、コンドロイチン、ヒアルロン酸などの有益な化合物が含まれており、関節組織の維持と修復を助ける可能性があります。その結果、変形性関節症などの症状を緩和するのに役立ちます。

さらに、国立医学図書館の報告によると、天然卵殻膜（NEM）は、変形性膝関節症に伴う痛みやこわばりの治療に効果的で安全な選択肢です。NEMを1日1回500mg摂取すると、10日、30日、60日後において、関節の痛みとこわばりの両方がプラセボと比較して有意に減少しました。

卵殻膜の効用に対する消費者の意識の高まり

卵殻膜の効用に対する消費者の意識の高まりが、世界の卵殻膜エキス市場を大きく牽引しています。卵殻膜にはコラーゲンやグルコサミンなど、関節の健康に欠かせない天然成分が含まれています。また、カルシウムやその他のミネラルのような必須栄養素も含まれており、全体的な骨の健康に貢献しています。

さらに、多くの製造会社が製品を発売しています。例えば、ストラタム・ニュートリション社が製造するNEMは、再生可能な米国産卵殻を原料としています。痛み、こわばり、軟骨の破壊に対して、わずか4～11日で健康な関節をサポートします。したがって、このような製品イノベーションを実施することで、より高い受容率と使用率に貢献することができます。

ビーガン動向の高まり

例えば、世界動物基金（World Animal Foundation）の最新データによると、2023年には世界中で8,800万人のビーガンがいると言われており、ビーガニズムとビーガンの傾向は大幅に増加しています。卵殻派生物は動物由来のものが多いため、ビーガン人口の増加は普及率に影響を与え、市場成長の低下を引き起こす可能性があります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 関節痛治療用卵殻膜誘導体に対する需要の増加
      • 卵殻膜の利点に関する消費者の意識の高まり
    • 抑制要因
      • 菜食主義者の動向の高まり
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品形態別

  • 粉末
  • 濃縮
  • カプセル
  • その他

第8章 包装別

  • ボトル
  • パウチ
  • その他

第9章 流通チャネル別

  • ハイパーマーケット／スーパーマーケット
  • 専門店
  • その他

第10章 用途別

  • 栄養補助食品
  • 飲食品
  • 化粧品・パーソナルケア
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Biova LLC
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Kewpie Corporation
  • Microcore.
  • Bolise Co., Ltd.
  • Certified Nutraceuticals Inc.
  • Ecovatec Solutions Inc.
  • EGGBRANE
  • Eggnovo
  • Stratum Nutrition
  • NOW Health Group, Inc.

第14章 付録

目次
Product Code: FB8083

Overview

Global Eggshell Membrane Derivatives Market reached US$ 789.1 million in 2022 and is expected to reach US$ 1335.67 million by 2030, growing with a CAGR of 6.8% during the forecast period 2023-2030.

The demand for eggshell membrane derivatives is rising among various pharmaceuticals, nutraceuticals, and cosmetics industries as these derivatives are rich in proteins, collagen, glycosaminoglycans, elastin, and other essential nutrients, which contributes to the growth of the global eggshell membrane derivatives market.

Furthermore, as the demand for eggshell membrane derivates products is rising, manufacturers of various industries are innovatively developing and incorporating the eggshell membrane in their portfolios. For instance, in October 2021, Ancient Nutrition launched a new line of collagen peptides. they are fermented eggshell membranes, that help to support healthy hair, skin, nails, joints, and gut. The peptides also improve the appearance of crow's feet, reduce joint discomfort, help joints recover faster, and reduce collagen degradation

The capsules made of eggshell membrane extracts account for the largest share in the global egg shell membrane derivatives market, as well as European region shows dominance in the world share, as the manufacturing companies in this region are strategically planning for developing and expanding the products in this region.

Dynamics

Increasing Demand for Eggshell Membrane Derivates for Joint Pain Treatment

The pharmaceutical industry is increasingly using eggshell membrane derivatives as a substitute for synthetic ingredients. These derivatives contain beneficial compounds, such as collagen, glucosamine, chondroitin, and hyaluronic acid, which may aid in the maintenance and repair of joint tissues. As a result, they can help alleviate symptoms associated with conditions like osteoarthritis.

In addition, according to the National Library of Medicine report, Natural Eggshell Membrane (NEM) is an effective and safe option for the treatment of pain and stiffness associated with knee osteoarthritis. Supplementation with NEM, 500 mg taken once daily, significantly reduced both joint pain and stiffness compared to placebo at 10, 30, and 60 days.

Rising Consumer Awareness About the Benefits of Eggshell Membrane

The rising consumer awareness about the benefits of eggshell membranes is significantly driving the global eggshell membrane extract market. They have natural compounds such as collagen, glucosamine, and others which are essential for joint health. They also contain essential nutrients like calcium and other minerals, which contribute to overall bone health.

Furthermore, many manufacturing companies are launching products in their portfolios. For instance, Stratum Nutrition company produces NEM is sustainably sourced from a renewable supply of US-domestic eggshells. It helps support healthy joints against pain, stiffness, and cartilage breakdown in as little as 4-11 days. Hence, implementing such product innovations can contribute to a higher rate of acceptance and usage.

Rising in Vegan Trend

Veganism and vegan trends are rising significantly, for instance, according to the World Animal Foundation's most recent data of 2023,88 million vegans in the world. As eggshell derivatives are often sourced from animals, the rising vegan population can affect the adoption rate and cause a decline in market growth.

Segment Analysis

The global Eggshell Membrane Derivatives market is segmented based on product form, packaging, distribution channel, application, and region.

Rising Demand for Eggshell Membrane Derivatives Capsules

The capsules segment accounts for the maximum share of the global eggshell membrane derivatives market. Consumers are highly adopting these capsules as dietary supplements as they contain collagen, calcium, glucosamine, and others as major components, which help in reducing joint pains and maintaining bone health.

Furthermore, Manufacturing companies are currently developing innovative products by utilizing the eggshell membrane. For instance, NOW Health Group, Inc. has developed Eggshell Membrane 500 mg Capsules NEM can help maintain healthy articular cartilage and surrounding synovial tissue by nourishing joints and supporting a balanced immune response to typical daily wear and tear. NEM can help to promote normal joint comfort and flexibility, usually within 7-10 days.

Geographical Penetration

Manufacturing Companies Partnerships

Europe has been a dominant force in the global eggshell membrane derivatives market and its significance has only grown in the post-2020 era. Consumers in this region are adopting these eggshell membrane extracts for various pharmaceutical applications, as they offer natural collagen and others.

Furthermore, manufacturing companies are strategically planning on expanding their market sizes, for instance, in January 2024, Bioiberica partnered with Faes Farma in Spain for a finished supplement called Vitanatur Multicollagen. This formula combines 40 mg of Collavant n2, along with eggshell membrane, which contains types I, V, and X collagen, hyaluronic acid, magnesium, and vitamins C, K2, and D3, for joint, bone, and skin health support.

Competitive Landscape

The major global players in the market include Biova LLC, Kewpie Corporation, Microcore., Bolise Co., Ltd., Certified Nutraceuticals Inc., Ecovatec Solutions Inc., EGGBRANE, Eggnovo, Stratum Nutrition, and NOW Health Group, Inc.

COVID-19 Impact Analysis

The production and processing of eggshell membrane derivatives has been halted due to COVID-19 implications. This has resulted in a decrease in stock production, causing a reduction in the industry's revenue. The supply chain has been disrupted due to a lack of transportation of raw materials and goods, leading to a mismatch between market demand and supply. As a result, consumers are unable to receive the goods, which has severely impacted the firm's revenue.

By Product Form

  • Powder
  • Concentrated
  • Capsules
  • Others

By Packaging

  • Bottles
  • Pouches
  • Others

By Distribution Channel

  • Hypermarkets/Supermarkets
  • Specialty Stores
  • Others

By Application

  • Nutraceuticals
  • Food & Beverages
  • Cosmetics & Personal Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In November 2023, Hardeman Egg Group acquired egg processing and trading company Egga Food Group including egg dying company Eivo. With this acquisition, Hardeman Egg Group intends to strengthen its international market position.
  • In October 2023, Cal-Maine Foods, Inc. acquired all the assets of Fassio Egg Farms, Inc., related to its commercial shell egg production and processing business. The acquired assets include commercial shell egg production and processing facilities with a current capacity of approximately 1.2 million laying hens, and others.
  • In April 2022, the Ready Egg Group acquired Skea Egg Farms Ltd. The acquisition of Skea Egg Farms Ltd has allowed for further diversification in the group, cementing its position as a leading player in the market.

Why Purchase the Report?

  • To visualize the global eggshell membrane derivatives market segmentation based on product form, packaging, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of eggshell membrane derivatives market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global eggshell membrane derivatives market report would provide approximately 70 tables, 64 figures, and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Product Form
  • 3.2.Snippet by Packaging
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Application
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Demand for Eggshell Membrane Derivates for Joint Pain Treatment
      • 4.1.1.2. Rising Consumer Awareness About the Benefits of Eggshell Membrane
    • 4.1.2.Restraints
      • 4.1.2.1.Rising in Vegan Trend
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Product Form

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 7.1.2.Market Attractiveness Index, By Product Form
  • 7.2.Powder*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Concentrated
  • 7.4.Capsules
  • 7.5.Others

8.By Packaging

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 8.1.2.Market Attractiveness Index, By Packaging
  • 8.2.Bottles*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Pouches
  • 8.4.Others

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.Hypermarkets/Supermarkets*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Specialty Stores
  • 9.4.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Nutraceuticals*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Food & Beverages
  • 10.4.Cosmetics & Personal Care
  • 10.5.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Biova LLC*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Kewpie Corporation
  • 13.3.Microcore.
  • 13.4.Bolise Co., Ltd.
  • 13.5.Certified Nutraceuticals Inc.
  • 13.6.Ecovatec Solutions Inc.
  • 13.7.EGGBRANE
  • 13.8.Eggnovo
  • 13.9.Stratum Nutrition
  • 13.10.NOW Health Group, Inc.

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us